Engineering functional BMP-2 expressing teratoma-derived fibroblasts for enhancing osteogenesis

Yoon Young Go, Ji Yeon Mun, Sung Won Chae, Shin Hye Kim, Hoseok Song, Jae Jun Song

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Bone morphogenetic protein 2 (BMP-2) is considered an effective growth factor for bone formation, and is used for making osteo-inductive scaffolds, but the related clinical investigations have shown low success rates. In this study, we genetically manipulated teratoma-derived fibroblast (TDF) cells by simultaneous introduction of BMP-2 and herpes simplex virus-thymidine kinase (HSV-tk) encoding genes. Self-production of BMP-2 in TDF cells strongly enhanced the alkaline phosphatase (ALP) activity, calcium content, and elevated the mRNA expression of osteogenic marker genes during in vitro osteogenesis. The bone formation volume was also remarkably enhanced in calvarial and femoral critical-size defect models. Ganciclovir (GCV) treatment induced apoptosis in TDF cells co-expressing HSV-tk and BMP-2, implying that HSV-tk suicide gene can modulate the side-effects of stem cell therapy, e.g., development of uncontrollable teratoma and tumor formation. Altogether, our findings revealed a safe and highly efficient technique with potential therapeutic applications for bone regeneration.

Original languageEnglish
Article number14581
JournalScientific reports
Issue number1
Publication statusPublished - 2018 Dec 1

Bibliographical note

Funding Information:
This work was supported by Korean Health Technology Research and Development Project, Ministry of Health and Welfare (HI15C2835), Republic of Korea.

Publisher Copyright:
© 2018, The Author(s).

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Engineering functional BMP-2 expressing teratoma-derived fibroblasts for enhancing osteogenesis'. Together they form a unique fingerprint.

Cite this